Ontvang nu dagelijks onze kooptips!

word abonnee
Van beleggers
voor beleggers
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
  • Word abonnee

  • Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?
Home Markt vandaag Koersen Forum Premium IEX Expert
Home  /  Forum  /  OCI  /  OCI - 2021

Aandeel OCI AEX:OCI.NL, NL0010558797

Laatste koers (eur) Verschil Volume
23,300   -0,100   (-0,43%) Dagrange 23,080 - 23,410 312.725   Gem. (3M) 297,4K

OCI - 2021

Volgen
7.828 Posts
Pagina: «« 1 ... 32 33 34 35 36 ... 392 »» | Laatste | Omlaag ↓
  1. forum rang 6 Plein777 18 februari 2021 10:44
    En weg is het vertrouwen in K+S. ( koers nu -13% )

    2019, as well as June 30, 2020, by the German Audit Office for Accounting at the occasion-related request of the German Federal Financial Supervisory Authority

    02-17-2021
    At the occasion-related request of the German Federal Financial Supervisory Authority ("Bundesanstalt für Finanzdienstleistungsaufsicht - BaFin"), the German Audit Office for Accounting ("Deutsche Prüfstelle für Rechnungslegungsaufsicht - DPR") examines the consolidated financial statements of K+S Aktiengesellschaft ("K+S") as of December 31, 2019, together with the related interim group management report and the abbreviated financial statements as of June 30, 2020.
    BaFin informed DPR about the reason for the examination as follows:

    “Specific indications exist because the assets reported in the consolidated financial statements as of December 31, 2019, and the abbreviated financial statements as of June 30, 2020, in particular non-current assets, may be overstated. According to IAS 36, among other things, assets are to be tested for impairment if facts and circumstances indicate that the book value of such an asset exceeds its recoverable amount. If facts and circumstances indicate that this is the case, an entity shall measure, present and explain any impairment loss in accordance with IAS 36.

    According to the ad hoc release of K+S Aktiengesellschaft dated November 4, 2020, the assumptions regarding the long-term potash price development are now lower and regarding the cost of capital higher than previously assumed. This resulted in an impairment requirement in the Europe+ operating unit of around € 2 billion in the quarterly financial statements as of September 30, 2020.”

    BaFin has concrete indications that this impairment requirement may not have been determined correctly and should have been recognized in full or in part at an earlier date. Other asset items may also be affected by the need for an impairment loss.

    There are therefore also indications that any required error correction in accordance with IAS 8 was not carried out.”

    DPR has indicated that it reserves the right to extend the examination to further items if further indications of incorrect accounting become known.

    K+S has informed DPR about its willingness to cooperate fully in the examination and to provide all necessary documents. The Board of Executive Directors assumes that it will be able to invalidate the BaFin's indications.

    Further information is available at www.kpluss.com.
  3. forum rang 6 Plein777 18 februari 2021 12:55
    quote:

    Just lucky schreef op 18 februari 2021 12:13:

    We zitten nu in een waardeloze markt; totaal geen omzet en elke basispunt die de futures van de yanken dalen wordt alles, waaronder OCI, direct lager gezet door de marktalgo's. Bij een correctie staan we ook direct weer ruim onder de 18. Afwachten maar....
    OCI ir relations zijn nog steeds te belazerd om de financial calender bij te houden :

    Events
    06 November 2020 Q3 2020 Results

    20. October 2020. Extraordinary General Meeting of Shareholders

    27 August 2020. Q2 2020 Results

    17. June 2020. Annual General Meeting of Shareholders
  4. forum rang 4 eduardo3105 18 februari 2021 13:11
    quote:

    Plein777 schreef op 18 februari 2021 12:55:

    [...]

    OCI ir relations zijn nog steeds te belazerd om de financial calender bij te houden :

    Events
    06 November 2020 Q3 2020 Results

    20. October 2020. Extraordinary General Meeting of Shareholders

    27 August 2020. Q2 2020 Results

    17. June 2020. Annual General Meeting of Shareholders
    En reageren doen ze ook niet ondanks al 2 reminders
  5. forum rang 6 de schaatser 18 februari 2021 14:05
    quote:

    RJ 80 schreef op 17 februari 2021 17:38:

    Nee, maar moet dat dan? Of zit je alleen vandaag in het aandeel? Wat consolidatie zo nu en dan is te verwachten na de mooie stijging afgelopen maanden. Ik vind het juist prima af en toe zo'n dag, geeft wat minder 'hoogtevrees' telkens voor daarna....
    Droom maar lekker verder.
  7. forum rang 6 de schaatser 18 februari 2021 16:24
    quote:

    Just lucky schreef op 18 februari 2021 15:57:

    CF had toch best goede cijfers en een mooi outlook, maar nu toch gewoon dik in de min.

    Ben benieuwd wat de reactie zal zijn op de cijfers van OCI volgende week.
    Aanvankelijk zelfs nog heel even in de plus. Maar nu is CF zelfs 2,4 % in de min.
    En dan te bedenken gister na beurs +/+ 1,8 %.
    Binnen 20 uur 4,2 % negatief.
    Yara blijft redelijk hangen.
    Ik vind het echt waardeloos dat je niet zeker weet wanneer de cijfers komen.

    Vanwege deze onzekerheid gehandeld:
    Ik heb net alle Oci's verkocht. En alles op de Call optie maart 2021 18.00 euro geplaatst.
    Theoretische kan ik niet meer dan 25 % van mijn winst verliezen.
    maar blijf toch ook mooi volledig in de eventuele koers stijging mee draaien.
  11. [verwijderd] 18 februari 2021 17:03
    Nutrien Gains 4% As 4Q Earnings Top Analysts’ Estimates; Street Says Hold

    More content below
    support@smarteranalyst.com (Ben Mahaney)
    Thu, February 18, 2021, 3:30 PM

    More content below

    NTR
    +0.02%
    Nutrien Ltd. delivered better-than-expected results in the fourth quarter as the crop inputs and services provider saw higher potash and nitrogen sales volumes and reduced production costs. Shares gained 3.8% in Wednesday’s after-market trading session.

    Nutrien (NTR) posted earnings per share (EPS) of $0.24 during the fourth quarter, topping analysts’ expectations of $0.18. Revenue rose 17% year-on-year to $4.05 billion, beating analysts’ estimates of $3.52 billion. Fourth-quarter revenue growth was primarily attributable to the 22% increase in crop nutrient product sales and a 30% increase in crop protection product sales.

    For fiscal 2020, the company generated sales of $20.91 billion, up from the $20.08 billion posted in 2019. Diluted earnings per share came in at $1.80.

    Nutrien CEO Chuck Margo said, “Agriculture fundamentals began to improve in late 2020 and we are starting to see the benefit to our business from this cyclical recovery.”

    Additionally, Nutrien ramped up its quarterly dividend to $0.46 per share from $0.45 earlier. This marks the company’s third consecutive dividend hike in the last three years. Furthermore, the company also approved a share repurchase plan of up to 5% of its outstanding shares over a period of one year.

    Looking ahead to fiscal 2021, Nutrien sees EPS land between $2.05 to $2.75 and adjusted EBITDA to come in between $4 billion to $4.5 billion. (See Nutrien stock analysis on TipRanks)

    On Feb. 9 Raymond James analyst Steve Hansen raised Nutrien’s price target to $65 (16.4% upside potential) from $55 and reiterated a Buy rating. Hansen notes, the “robust, demand-driven surge” in global crop prices as “fundamentally constructive” for crop input demand and fertilizer prices.

    The rest of the Street has a Moderate Buy consensus rating on the stock based on 5 Buys, 3 Holds and 1 Sell. The average analyst price target of $53.31 implies about 4.6% downside from
  19. [verwijderd] 18 februari 2021 18:13
    De verwachtingen om akkers in te zaaien worden naar boven bijgesteld,nog meer kunstmest.

    USDA signals acreage expansions in outlook
    TAGS: FARM FUTURES MARKET COMMENTARY CROPS USDA CORN SOYBEANS
    Vstock-LLC/ThinkstockCombine unloading grain in evening glow.
    USDA Chief Economist Meyer predicts 92M acres of corn, 90M acres of soybeans in 2021.
    Jacqueline Holland | Feb 18, 2021

    USDA’s 97th Annual Agricultural Outlook Forum kicked off this morning. Chief Economist Seth Meyer opened the sessions with an economic and foreign trade outlook for the agriculture industry, highlighting the opportunities and challenges facing the farm and food community for the year to come.

    Record corn, soy expansion
    The top headline from the opening session was USDA’s 2021 acreage estimations. At this time, USDA forecasts U.S. farmers will plant 92 million acres of corn in 2021 and 90 million acres of soybeans – the largest ever combined acreage for both crops. A second year of record prevent plant acreage and late season growing struggles in the Heartland left 2020 acreage at 90.8 million acres for corn and 83.1 million acres for soybeans.

    A Farm Futures survey released in January 2021 predicted farmers to be increasingly bullish on 2021 corn expansion compared to USDA. Farm Futures’ new crop corn acreage was 94.7 million acres and 84.5 million acres of soybeans in the early January survey. Of course, these early planting estimates are all subject to change ahead of peak planting season in late March based on economic conditions, crop and input prices, and weather.
7.828 Posts
Pagina: «« 1 ... 32 33 34 35 36 ... 392 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Premium

Beleggers willen meer duidelijkheid van OCI

Het laatste advies leest u als abonnee van IEX Premium

Inloggen Word Abonnee

OCI Nieuws

  1. ING verlaagt koersdoel OCI licht
  2. Jefferies zet OCI op de kooplijst
  3. AEX opent beursweek aarzelend, maar beleggers scherpen de messen
  4. Beursblik: geen verrassingen bij OCI
  5. Vlakke start AEX, maar het venijn zit vandaag in de staart
  6. OCI lijdt onder lagere stikstofprijzen
  7. Kamervragen over truc 'belastingontwijking' OCI
  8. OCI levert klimaatvriendelijke ammoniak aan Compo Expert
  9. FT: Sawiris overweegt OCI verder op te breken
  10. Update: OCI keert minimaal 3 miljard dollar uit